cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verrica Pharmaceuticals Inc
2 own
5 watching
Current Price
$6.34
$0.62
(10.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
260.54M
52-Week High
52-Week High
9.22
52-Week Low
52-Week Low
1.77
Average Volume
Average Volume
0.51M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization260.54M
icon52-Week High9.22
icon52-Week Low1.77
iconAverage Volume0.51M
iconDividend Yield--
iconP/E Ratio--
What does the Verrica Pharmaceuticals Inc do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company s lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More
How much money does Verrica Pharmaceuticals Inc make?
News & Events about Verrica Pharmaceuticals Inc.
Globe Newswire
1month ago
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
2 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...
Zolmax
2 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, ...
PR Newswire
6 months ago
VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 PR Newswire NEW YORK, Aug. 5, 2022 NEW YORK, Aug. 5, 2022...
PR Newswire
6 months ago
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS...
Frequently Asked Questions
Frequently Asked Questions
What is Verrica Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Verrica Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Verrica Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Verrica Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verrica Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verrica Pharmaceuticals Inc?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.34
$0.62
(10.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$4.34
$-0.15 (-3.34 %)
Nkarta Inc
Nkarta Inc
$5.57
$-0.07 (-1.24 %)
Ocugen Inc
Ocugen Inc
$1.16
$-0.08 (-6.45 %)
Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc.
$4.28
$-0.22 (-4.89 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$4.34
$-0.15 (-3.34 %)
Nkarta Inc
Nkarta Inc
$5.57
$-0.07 (-1.24 %)
Ocugen Inc
Ocugen Inc
$1.16
$-0.08 (-6.45 %)
Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc.
$4.28
$-0.22 (-4.89 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00